Failure of oral tyrosine supplementation to improve exercise performance in the heat by Tumilty, Les et al.
Aberystwyth University
Failure of oral tyrosine supplementation to improve exercise performance in the
heat
Tumilty, Les; Davison, Glen; Beckmann, Manfred; Thatcher, Rhys
Published in:
Medicine and Science in Sports and Exercise
DOI:
10.1249/MSS.0000000000000243
Publication date:
2014
Citation for published version (APA):
Tumilty, L., Davison, G., Beckmann, M., & Thatcher, R. (2014). Failure of oral tyrosine supplementation to
improve exercise performance in the heat. Medicine and Science in Sports and Exercise, 46(7), 1417-25.
https://doi.org/10.1249/MSS.0000000000000243
Document License
Unspecified
General rights
Copyright and moral rights for the publications made accessible in the Aberystwyth Research Portal (the Institutional Repository) are
retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the
legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the Aberystwyth Research Portal for the purpose of private study or
research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the Aberystwyth Research Portal
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
tel: +44 1970 62 2400
email: is@aber.ac.uk
Download date: 03. Oct. 2019
Failure of Oral Tyrosine Supplementation to
Improve Exercise Performance in the Heat
LES TUMILTY1, GLEN DAVISON2, MANFRED BECKMANN3, and RHYS THATCHER1
1Department of Sport and Exercise Science, Aberystwyth University, Wales, UNITED KINGDOM; 2Endurance Research
Group, Centre for Sports Studies, University of Kent at Medway, Chatham, UNITED KINGDOM; and 3Institute of Biological,
Environmental and Rural Sciences, Aberystwyth University, Wales, UNITED KINGDOM
ABSTRACT
TUMILTY, L., G. DAVISON, M. BECKMANN, and R. THATCHER. Failure of Oral Tyrosine Supplementation to Improve Exercise
Performance in the Heat.Med. Sci. Sports Exerc., Vol. 46, No. 7, pp. 1417–1425, 2014. Purpose: Acute oral tyrosine administration has
been associated with increased constant-load, submaximal exercise capacity in the heat. This study sought to determine whether self-
paced exercise performance in the heat is enhanced with the same tyrosine dosage. Methods: After familiarization, seven male
endurance-trained volunteers, unacclimated to exercise in the heat, performed two experimental trials in 30-C (60% relative humidity) in
a crossover fashion separated by at least 7 d. Subjects ingested 150 mgIkgj1 body mass tyrosine (TYR) or an isocaloric quantity of whey
powder (PLA) in 500 mL of sugar-free flavored water in a randomized, double-blind fashion. Sixty minutes after drink ingestion, the
subjects cycled for 60 min at 57% T 4% peak oxygen uptake (V˙O2peak) and then performed a simulated cycling time trial requiring
completion of an individualized target work quantity (393.1 T 39.8 kJ).Results: The ratio of plasma tyrosine plus phenylalanine (tyrosine
precursor) to amino acids competing for brain uptake (free-tryptophan, leucine, isoleucine, valine, methionine, threonine, and lysine)
increased 2.5-fold from rest in TYR and remained elevated throughout exercise (P G 0.001), whereas it declined in PLA from rest to
preexercise (P = 0.004). Time-trial power output (P = 0.869) and performance (34.8 T 6.5 and 35.2 T 8.3 min in TYR and PLA,
respectively; P = 0.4167) were similar between trials. Thermal sensation (P 9 0.05), RPE (P 9 0.05), core temperature (P = 0.860), skin
temperature (P = 0.822), and heart rate (P = 0.314) did not differ between trials. Conclusions: These data indicate that acute tyrosine
administration did not influence self-paced endurance exercise performance in the heat. Plasma tyrosine availability is apparently not a key
determinant of fatigue processes under these conditions.KeyWords: AMINO ACIDS, CATECHOLAMINES, MILD HYPERTHERMIA,
CENTRAL FATIGUE, PROLONGED EXERCISE
E
xercise performance is clearly impaired in high am-
bient temperature compared with cooler conditions
(33). This impairment has been primarily attributed
to fatigue caused by central nervous system changes, sec-
ondary to increased brain temperature (21), although periph-
eral factors including high skin temperature, dehydration, and
alterations in circulatory and thermoregulatory factors, also
likely contribute to this (6,28). A definitive neurobiological
cause has yet to be established for this central fatigue, but
one or several neurochemical systems are likely to be involved.
There is a well-defined role for the brain catecholamines do-
pamine and noradrenaline in increased motivation, arousal, and
reward (4); acute stress responses (26); motor initiation and
control (14); and thermoregulation (9). Therefore, it is plausible
that these neurotransmitters modulate the central fatigue as-
sociated with prolonged exercise in the heat.
The amino acid tyrosine is a nutritional substrate precursor
for dopamine and noradrenaline (38). Brain tyrosine concen-
trations are above the Km for tyrosine hydroxylase, the rate-
limiting enzyme in catecholamine synthesis (8). Catecholamine
synthesis and release is also limited by neuronal firing rate
so that during periods of low impulse flow, tyrosine hydroxy-
lase is highly susceptible to catecholamine end-product in-
hibition (8). Microdialysis measurements in the rat confirm
that the augmentation of cerebral catecholamine release after
systemic tyrosine injection, while under basal conditions,
is generally limited in magnitude and duration (12). In animals
exposed to extreme environmental stress that substantially
increases impulse flow through catecholamine neurons, such
as nigrostriatal lesioning, electrical stimulation of cerebral cat-
echolamine pathways, or tail shock, neurotransmitter turnover
is elevated, and tyrosine may be depleted in some neuronal
populations (5,12,17). Tyrosine hydroxylase then exhibits
increased affinity for tyrosine coupled with a decreased sen-
sitivity to catecholamine end-product inhibition (27). Under
these conditions, tyrosine administered to rats by injection
or dietary means maintains cerebral tyrosine levels and aug-
ments central nervous system catecholamine turnover in acti-
vated neuronal populations (17,32). Impairments in locomotion,
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exploratory behavior, memory, and coping behavior in rats
exposed to acute, experimentally induced stress, such as tail
shock and heat or cold exposure, are also countered by tyro-
sine administration (17,18,39). There is also a large body of
evidence that cognitive, psychomotor, and mood impair-
ments and symptom intensity in humans induced by de-
manding environmental conditions such as cold, hypoxia, or
prolonged wakefulness are countered by increasing plasma
tyrosine availability via acute oral administration before ex-
posure to the environmental conditions (1,19,20). Evidence
supporting an enhancement of exercise in humans after acute
tyrosine supplementation is less clear. Studies have gener-
ally failed to show benefits of acute tyrosine administration
on exercise capacity, exercise performance, muscle strength,
and anaerobic power in temperate ambient conditions (7,30,31).
There are mixed reports of the effectiveness of tyrosine
supplementation before prolonged exercise in the heat. One
recent study reported improved capacity to perform constant-
load submaximal-intensity exercise in 30-C heat (60% rela-
tive humidity) after an acute administration of 150 mgIkgj1
body mass tyrosine (34), but a separate study using a similar
protocol and tyrosine dosage failed to show an effect (35).
Both Tumilty et al. (34) and Watson et al. (35) reported a
marked increase in the ratio of plasma tyrosine to neutral
amino acids that compete for brain uptake after supplemen-
tation. This ratio is a key determinant of brain uptake of a
single amino acid rather than the plasma concentration of the
amino acid per se, as there are several neutral amino acids
competing for a shared, saturable carrier molecule across the
blood–brain barrier (13). Therefore, increasing the plasma con-
centration of a single amino acid, or the concentration of com-
peting amino acids, will increase or decrease the brain uptake
of a given amino acid, respectively (13).
To date, no study has assessed whether exercise perfor-
mance (e.g., a time trial) in the heat is augmented by high
tyrosine availability despite evidence that tyrosine supple-
mentation counters the adverse effects of challenging envi-
ronmental conditions. Because of the self-paced nature of a
performance time trial, which will be highly influenced by
motivation and arousal, it is plausible that any improvements
after tyrosine supplementation would be more apparent dur-
ing this type of exercise trial compared with a constant-load
capacity trial. Therefore, the present study was designed to
test the hypothesis that acute tyrosine administration would
improve exercise performance in the heat.
METHODS
Subjects. Eight male volunteers, unacclimated to exer-
cise in the heat and participating in regular endurance training
at least four times per week, gave written informed consent
to take part in the study. This sample size provided sufficient
power in a previous study to highlight an effect of tyrosine
supplementation on prolonged exercise capacity in the heat
(34). One subject did not complete testing because of injury,
and the corresponding data were omitted from all statistical
analysis. The remaining seven subjects, classified as perfor-
mance level 3 (10) (six competitive cyclists and one com-
petitive runner with regular experience of cycling; median
age = 20 yr, range = 26 yr; median stature = 1.83 m, range =
0.13 m; mean T SD for body mass = 77.9 T 11.7 kg; peak
oxygen uptake (V˙O2peak) = 60 T 11 mLIkg
j1Iminj1; peak
power output attained during ramp test on a cycle ergometer
to elicit V˙O2peak = 389 T 44 W; maximal heart rate attained
during ramp test = 186 T 8 bpm), completed all trials. Testing
was carried out between October and June in Wales within
the UK when the average daytime air temperature typically
ranges between 3-C and 17-C. All subjects were resident
here for at least 1 month before the commencement of test-
ing. The study was approved by Aberystwyth University
Research Ethics Committee.
Experimental procedures. Subjects visited the labo-
ratory on five separate occasions: an initial ramp test to de-
termine peak power output, maximal heart rate, and V˙O2peak
using an online breath-by-breath system (Jager Oxycon Pro,
Hoechberg, Germany); two familiarization visits, and two
main experimental trials. No strenuous or unaccustomed ex-
ercise was permitted for 24 h before each test. Subjects were
instructed to sleep for Q8 h the night before each laboratory
visit to ensure they were rested, and verbal confirmation of
adherence to this was given on arrival for each test day. All
exercise was performed on an electrically braked cycle ergo-
meter (Lode Excalibur Sport, Groningen, Netherlands). Sub-
jects wore comfortable clothing, which was kept consistent
between trials, typically consisting of shorts, T-shirt, and sports
shoes or cycling shorts, short-sleeved cycling top, and cycling
shoes. During the ramp test, power output was increased at a
rate of 0.5 WIsj1 until the subject reached volitional exhaus-
tion, and V˙O2peak was determined as the highest oxygen uptake
(V˙O2) averaged over a 30-s period. Gas exchange threshold
was identified using the v-slope method, determined as the
first disproportionate increase in carbon dioxide output (V˙CO2)
relative to V˙O2 and an increase in the ventilatory equivalent
for V˙O2 in relation to a leveling off or continued decrease in
the ventilatory equivalent for V˙CO2 (2). Heart rate was re-
corded continuously during all trials using radiotelemetry
(Polar RS800CX; Polar Electro Oy, Tampere, Finland), and
the peak value measured during the ramp test was recorded
as maximal heart rate. At least 48 h elapsed between the ramp
test and the first familiarization visit, and at least 7 d separated
each of the remaining four trials. The familiarization visits
were designed to appease any anxiety and to allow subjects
to become accustomed to the time-trial protocol in the heat.
These visits were identical with the main experimental trials
except that blood samples were not taken and the placebo
drink (see below) was administered for both familiariza-
tions. All of the familiarization and main trials commenced
between 0630 and 0930 h, with each subject performing all
four trials at the same time of day to control for diurnal
variation. Subjects recorded their food and drink intake for
48 h and physical activity for 24 h before the first familiar-
ization, and this enabled duplication before each subsequent
http://www.acsm-msse.org1418 Official Journal of the American College of Sports Medicine
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visit. After arriving at the laboratory after an overnight fast
of at least 8 h, except for 500 mL of ordinary tap water, which
they drank exactly 2 h before arriving, subjects emptied their
bladder into a Pyrex beaker. Urine volume was measured to
the nearest milliliter before a 1.0-mL aliquot was frozen at
j80-C for later measurement of osomolality, in duplicate,
using freezing point depression (Osmostat 030; Gonotec,
Berlin, Germany). Nude, postvoid body mass was mea-
sured to the nearest 0.1 kg (Seca 645; Seca GMB and Co.,
Hamburg, Germany), and stature was recorded (stadiometer;
Holtain Ltd., Crymych, UK). A rectal thermistor (Grant
Instruments, Cambridge, England, UK) was self-positioned
by each subject 10 cm beyond the anal sphincter to enable
core temperature measurement (Tcore), and surface skin tem-
perature probes (Grant Instruments) were attached to the
calf, thigh, chest, and triceps using breathable medical tape
(Hypafix, Bsn Medical, Hull, UK) so skin temperature (Tskin)
could be measured. Tcore and Tskin were recorded from an
electronic data logger (Squirrel SQ2020; Grant Instruments),
and from these data, mean weighted skin temperature was
calculated (24). Subjects were seated for 15 min to minimize
the effect of plasma volume changes before a 10.5-mL rest-
ing blood sample was obtained (Rest), with minimal stasis,
from an antecubital vein, comprising 6 mL into a heparinized
vacutainer and 4.5 mL into a K3EDTA-treated vacutainer
(BD Vacutainer Systems, Plymouth, UK). The experimental
or placebo drink were administered in a randomized, double-
blind and counterbalanced manner before subjects were
seated in a quiet, comfortable environment (20.5-C T 0.4-C,
44% T 6% relative humidity) for 1 h. The experimental drink
(TYR) contained 150 mgIkgj1 body mass tyrosine (SHS
international Ltd., Liverpool, UK) and 7 g vanilla flavoring
(Myprotein.co.uk, Cheadle, Cheshire, UK) in 500 mL of
fluid (ordinary tap water with 40% sugar-free lemon and
lime squash; Morrisons, Bradford, UK). This tyrosine dosage
was associated with increased exercise capacity in the heat
in an earlier study (34). The placebo drink (PLA) contained
the same fluid volume and content, with an isocaloric quan-
tity of hydrolyzed whey protein (Myprotein.co.uk) instead
of tyrosine (equating to 11.6 T 1.6 g tyrosine or 6.1 T 0.8 g
whey protein; 22 T 3 kcal) to ensure any performance effects
of tyrosine were not due to the additional energy content of
the experimental drink. All drinks were coded and prepared
by a separate drinks supervisor to ensure they were allocated
in a double-blind manner. Previous pilot work with three
volunteers who did not participate in this study confirmed that
the drinks were indistinguishable in color, taste, and texture.
Care was taken to properly blend the mixtures, which were
served in opaque drinking bottles and were shaken vigorously
immediately before ingestion. At the end of the 1-h period, a
second 10.5 mL blood sample (Pre) was taken before sub-
jects entered the climate chamber (Design Environmental,
Gwent, Wales). The temperature and the relative humidity of
the chamber were maintained at 30.1-C T 0.2-C and 60% T 0%,
respectively, and the mean air velocity within the chamber was
0.26 T 0.1 mIsj1 during all trials. Once inside the chamber,
subjects commenced cycling, without a warm-up, at a con-
stant power output equivalent to 10% $ (power output re-
quiring a V˙O2 that is 10% of the difference between the
V˙O2 at the gas exchange threshold and the V˙O2peak [16];
156 T 24 W or 57% T 4% V˙O2peak in this subject group) for
60 min. The purpose of this exercise period was to induce
hyperthermia before the commencement of the time trial.
No information on time elapsed or motivational encourage-
ment was given to the subjects throughout this exercise
period. Drinks (2 mLIkgj1 body mass ordinary tap water
with 20% sugar-free lemon and lime squash) were provided
at 15, 30, 45, and 59 min. At the end of the 60 min of cy-
cling, subjects were quickly removed to a chair directly ad-
jacent to the cycle ergometer within the climate chamber,
where a further 10.5 mL blood sample was obtained (Post
60). Subjects then remounted the cycle ergometer to perform
a simulated cycling time trial. A maximum of 2 min elapsed
between subjects dismounting the ergometer and the acqui-
sition of the Post 60 blood sample. The time taken to obtain
this sample and the time between the end of the 60 min of
cycling and the commencement of the time trial were stan-
dardized for each individual subject during subsequent trials.
The time trial was based on a validated protocol used in
previous research examining fatigue during prolonged exer-
cise in the heat (36) and requires subjects to complete a set
amount of work as quickly as possible. Individual target work
quantities were calculated for each subject as the amount of
work that would be completed during 30 min of cycling at
60% of the power output eliciting V˙O2peak during the initial
ramp test (393.1 T 39.8 kJ in this group). The cycle ergometer
was set in linear mode (workload increases as pedaling rate
increases) during the time trial so that the power output and
hence the completed work were directly related to pedaling
cadence. At the start of the time trial, subjects were given
their target work quantities and instructed to complete the
required amount of work as quickly as possible, and no
other instructions or motivational encouragement was given
throughout. The control console for the ergometer was po-
sitioned on the bike frame, and the display was masked with
nontransparent adhesive tape so that only the cumulative work
portion of the console display was visible. No further feed-
back on power output, cadence, or time elapsed was provided
throughout the time trial. A cumulative work target was also
taped to the front of the ergometer handlebars, in full view
of the subjects, which detailed the required work to achieve
25%, 50%, 75%, and 100% of their individual target. Sub-
jects were permitted to drink ad libitum throughout (ordinary
tap water with 20% sugar-free lemon and lime squash). On
completion of the time trial, subjects dismounted the cycle
ergometer, moved quickly to the adjacent chair where a final
10.5-mL blood sample (Post TT) was obtained within a maxi-
mum of 2 min, and this time was also standardized for each
individual subject during subsequent trials. Subjects emptied
their bladder, and urine volume was again recorded to the
nearest milliliter before a 1.0-mL aliquot was removed then
frozen at j80-C for later osmolality measurement. Finally,
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the thermistor and skin probes were removed before sub-
jects showered, toweled dry, and then reweighed nude.
Physiologicalmeasurements and blood analysis. Heart
rate, Tcore, and Tskin were recorded every 10 min throughout
60 min of rest and 60 min of submaximal exercise. Power
output, heart rate, Tcore, and Tskin were recorded at the start
of the time trial and every 5 min throughout exercise. RPE
(3) and thermal sensation, using a 21-point scale ranging from
j10 (cold impossible to bear) to +10 (heat impossible to
bear) (adapted from reference 22), were recorded every 10 min
throughout the 60-min submaximal exercise, after 5 min of
the time trial had elapsed, and then every 5 min throughout
the time trial. One-minute expired gas samples were collected in
Douglas bags at 30 and 50 min of the constant-load exercise
period. Oxygen and carbon dioxide concentrations were mea-
sured using a combined paramagnetic oxygen analyzer and in-
frared carbon dioxide analyzer (Series 4100 Xentra; Servomex,
Crowborough, UK), which were calibrated before each trial
using commercial gases (BOC, Guildford, UK), and expired
volume was measured using a dry gas meter (Harvard Appa-
ratus Ltd., Edenbridge, UK). Expired gases were used to esti-
mate fat and carbohydrate utilization and energy expenditure
(23). Final measurements of heart rate, Tcore, Tskin, RPE, ther-
mal sensation, and power output were recorded immediately
before subjects completed the time trial. Wind speed within
the chamber was measured every 15 min of exercise as the
mean value of four measurements taken from the front, from
behind, and to the left and right of each subject at head
height while seated on the cycle ergometer, using a hand-
held anemometer (Kestrel 1000; Richard Paul Russell Ltd.,
Lymington, UK).
Blood from the K3EDTA vacutainer was used to mea-
sure hematocrit, hemoglobin, lactate, and glucose. Whole
blood was drawn into microcapillary tubes, spun for 5 min at
14,000g using a Hawksley microcentrifuge (Haematospin
1400; Hawksley, Lancing, UK), and the separated red cell
volume was measured using a Hawksley hematocrit tube
reader, with a coefficient of variation of 0.8% for 10 repeated
measurements on the same sample. Hemoglobin was mea-
sured using an automated hematology analyzer (Pentra 60C+;
Horiba ABX Diagnostics, Northampton, UK), with a coef-
ficient of variation of 0.3% for 10 repeated measurements
on the same sample standard containing 14.0 gILj1 hemo-
globin. Hematocrit and hemoglobin measurements were
used to estimate plasma volume changes (11). Blood glucose
and blood lactate concentrations were measured using an
automated analyzer (2300 Stat Plus; Yellow Spring Instru-
ment Co., OH), calibrated with standard concentrations for
glucose (0.00 and 50.00 mmolILj1) and lactate (0.00 and
30.00 mmolILj1). The coefficient of variation for 10 re-
peated measurements on a sample standard for blood glucose
(6.14 mmolILj1) and blood lactate (5.35 mmolILj1) is 1.7%
and 1.5%, respectively. The heparinized blood was immedi-
ately centrifuged at 1500g for 10 min at 4-C, and then the
plasma was separated and stored at j80-C for later analysis
of amino acids using gas chromatography–mass spectrometry
(34). The coefficient of variation for the measurement of in-
dividual plasma amino acids using this technique is as follows:
leucine, 8.5%; isoleucine, 9.7%; valine, 5.8%; methionine,
11.4%; threonine, 8.7%; lysine, 5.0%; the free fraction of
tryptophan unbound from albumin (free-tryptophan), 5.2%;
phenylalanine, 7.5%; and tyrosine, 6.5%. Hematocrit was
measured in triplicate, and all remaining blood analyses were
measured in duplicate. All blood parameters were cor-
rected for plasma volume changes from baseline measure-
ments at Rest.
Statistical analyses. A computerized statistical pack-
age was used to analyze all data (SPSS version 17.0; SPSS
Inc., Chicago, IL). Normally distributed data are presented
as mean T SD. Time trial performance, urine osmolality, and
rate of body mass losses were examined using Student’s
paired t-test. Cohen’s d effect size was calculated for the
difference in time to complete the time trial. Differences
in data throughout trials were compared using a repeated-
measures two-factor (time  trial) ANOVA. Where signifi-
cant differences were found, post hoc analysis was carried
out using Student’s paired t-tests with the Bonferroni cor-
rection. End of time-trial values were analyzed separately
using Student’s paired t-test to account for the different
exercise duration between subjects and trials. Nonnormally
distributed data are presented as median (range) and were
analyzed using Friedman’s tests, and where appropriate,
post hoc tests were carried out using the Wilcoxon matched
pairs tests with the Bonferroni correction. Statistical signif-
icance was set at P G 0.05.
RESULTS
Time-trial performance. After the completion of all
trials, three subjects reported they felt better or more moti-
vated during the tyrosine trial, but could not distinguish
between the TYR and PLA drinks, two subjects incorrectly
thought they had received PLA when they had received
TYR, and the remaining two subjects were unable to distin-
guish between trials, indicating successful drinks-blinding.
The coefficient of variation for time to complete the time trial
between the second familiarization trial and the PLA trial
was 1.3% and there was no effect of trial order during the
experimental trials (P = 0.313). TYR did not influence the
time to complete the time trial (P = 0.417; 34.8 T 6.5 min in
TYR and 35.2 T 8.3 min in PLA; Fig. 1A) and power
output throughout the time trial was similar in both trials
(P = 0.869; Fig. 1B). The effect size for TYR versus PLA is
calculated as 0.05, and the resultant statistical power value
is 0.11. A SD of 0.6 would be required to detect significant
differences in time trial performance between TYR and
PLA with seven subjects per group, yielding an estimated
statistical power value of 0.80 (P = 0.05 [37]). Subjects’
performance was even paced up to 20 min of the time trial
(P = 0.061), which represented the last time point at which
all subjects were still exercising.
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Blood analysis. Plasma tyrosine concentration at Rest
was similar in both trials (P = 0.269; Fig. 2A) but was higher
in TYR at all remaining sampling times (P G 0.01), while
the concentration remained unchanged from Rest in PLA
(P 9 0.05). Plasma phenylalanine concentration was un-
changed at any time point in TYR (P 9 0.05) but was ele-
vated from Rest in PLA on the completion of the time trial
(P G 0.01). There was no difference between trials in the ratio
of plasma tyrosine plus phenylalanine to 3(free-tryptophan;
valine, leucine, isoleucine, threonine, methionine, lysine) at
Rest (P = 0.838; Fig. 2B), but the ratio was higher in TYR at
all other time points (P = 0.001). TYR ingestion increased
this ratio more than 2.5-fold (P G 0.001) from Rest and
remained elevated at all other sampling times (P G 0.001). In
PLA, there was a transient decline in this ratio from Rest
to preexercise (P = 0.004). The plasma concentrations of
the remaining individual amino acids analyzed are provided
in Table 1. Blood glucose concentration was unaffected by
drink ingested (P 9 0.05) or exercise (P = 0.801) and was
5.3 T 0.9 mmolILj1 in both trials at Post TT. At Post 60,
blood lactate concentration had increased from Rest in both
trials (P = 0.018), remaining elevated from Rest at Post TT
(P = 0.018), but did not differ between trials [P 9 0.05; 3.2
(range, 3.6) mmolILj1 in TYR and 4.1 (range, 4.9) mmolILj1
in PLA]. Plasma volume progressively declined, and to a
similar extent in both trials, after drink ingestion (P G 0.05)
reaching j8.4% T 6.0% in TYR and j9.1% T 4.5% in PLA
at end of the time trial.
Temperature measurements. Exercise caused a grad-
ual increase in Tcore (P = 0.003) at a similar rate in both trials
(P = 0.131; Fig. 3A). At the end of the time trial, Tcore was
39.0-C T 0.7-C in TYR and 38.9 T 0.6 in PLA (P = 0.474).
Tskin also increased during exercise (P = 0.012), plateauing
after 20 min of constant-load exercise and after 15 min of
the time trial (Fig. 3B). The drink ingested had no influence
on Tskin (P = 0.822), and there was no difference between
FIGURE 1—Mean T SD (columns and vertical error bars) and indi-
vidual (remaining individual lines) times to complete simulated cycling
time trial (A) and power output during time trial, up to the last time
point all subjects were exercising and value recorded at the end of the
time trial (B), in tyrosine (TYR) and placebo (PLA) trials. Data are
expressed as mean T SD (n = 7).
FIGURE 2—Changes in plasma tyrosine concentration (A) and tyro-
sine ratio [plasma concentration ratio of tyrosine plus phenylalanine
and 3(f-tryptophan; valine, leucine, isoleucine, threonine, methionine,
lysine)] (B) in tyrosine (TYR) and placebo (PLA) trials. TT, time trial.
##Significant difference between trials. ††Significantly different versus
Rest in TYR (P G 0.01). §Significantly different versus Rest in PLA
(P G 0.05). Data are expressed as mean T SD (n = 7).
TYROSINE AND ENDURANCE EXERCISE IN THE HEAT Medicine & Science in Sports & Exercised 1421
A
PPLIED
SC
IEN
C
ES
Copyright © 2014 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
trials in Tskin at end of the time trial (34.8-C T 0.8-C in TYR
and 35.0-C T 1.3-C in PLA; P = 0.575).
Heart rate. There was a gradual increase in heart rate
throughout exercise (Fig. 4; P G 0.001), which was unaffected
by drink ingested (P = 0.314). At end of the time trial, heart
rate reached 100% T 4% and 99% T 4% of maximum in TYR
and PLA, respectively (P = 0.729).
Urine analysis, fluid intake, and body mass
losses. Preexercise urine osmolality suggested that sub-
jects were similarly hydrated before both trials (P = 0.571;
329 T 136 mOsmIkgj1 in TYR and 369 T 148 mOsmIkgj1
in PLA). After the time trial, urine osmolality was sim-
ilar in each trial (198 T 56 mOsmIkgj1 in TYR and 325 T
296 mOsmIkgj1 in PLA; P = 0.218) and unchanged from
preexercise (P = 0.202). Subjects drank similar volumes of
fluid during the time trial in both trials (311.1 T 114.4 mL
in TYR and 363.0 T 126.1 mL in PLA; P = 0.415). By the
end of the time trial, body mass losses, calculated from the
difference between pre- and postexercise body mass adjusted
for fluid intake and urine output after initial weighing (2.9% T
0.7% and 3.1% T 1.1% of preexercise body mass in TYR and
PLA, respectively; P = 0.528), and the rate of body mass loss
TABLE 1. Plasma amino acid concentrations in tyrosine (TYR) and placebo (PLA) trials.
TYR PLA
Rest Pre Post 60 Post TT Rest Pre Post 60 Post TT
Amino acids (KmolILj1)
f-Tryptophan 149 (107) 152 (28) 150 (77) 162 (127) 155 (93) 160 (49) 154 (93) 172 (77)
Valine 158 (69) 135 (51) 159 (81) 143 (73) 165 (85) 166 (53) 144 (102) 161 (108)
Leucine 146 (74) 105 (79)* 130 (89) 131 (117) 154 (128) 181 (83)** 135 (115) 166 (84)
Isoleucine 83 (42) 66 (38)* 62 (35) 73 (43) 77 (75) 97 (42)** 76 (55) 86 (29)**
Threonine 92 (46) 99 (58) 96 (44) 92 (68) 120 (45) 118 (54) 104 (51) 121 (55)
Methionine 30 (9) 27 (9) 28 (9) 34 (22) 30 (9) 30 (7)** 31 (144) 36 (15)*
Lysine 254 (115) 251 (131) 216 (98) 215 (178) 226 (161) 276 (139) 253 (147) 246 (112)
3 (mmolILj1) 1.0 (0.4) 1.0 (0.3) 0.9 (0.3) 1.0 (0.3) 0.9 (0.3) 0.8 (0.3)** 0.9 (0.3) 0.8 (0.5)
Values are presented as median (range).
*Significantly different from Rest in same trial (P G 0.05, n = 7).
**Significant difference between trials (P G 0.05, n = 7).
f-Tryptophan, free-tryptophan; 3, 3(valine, leucine, isoleucine, threonine, methionine, lysine).
FIGURE 3—Core temperature (A) and mean weighted skin tempera-
ture (B) responses during a 1-h rest, 60 min of constant-load
submaximal-intensity exercise and simulated cycling time trial (TT),
up to the last time point that all subjects were exercising and value
recorded at end of TT, in tyrosine (TYR) and placebo (PLA) trials.
**Significantly different versus start value in both trials (P G 0.01).
Data are expressed as mean T SD (n = 7).
FIGURE 4—Heart rate responses during the 1-h rest, 60 min of
constant-load submaximal-intensity exercise and simulated cycling time
trial (TT), up to the last time point that all subjects were exercising
and value recorded at end of TT, in tyrosine (TYR), and placebo
(PLA) trials. **Significantly different versus start value in both trials
(P G 0.01). Data are expressed as mean T SD (n = 7).
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(P = 0.436; 4.0 T 1.0 kgIhj1 in TYR and 4.3 T 1.6 kgIhj1 in
PLA) were similar in both trials.
Subjective ratings. Expressed RPE gradually increased
throughout exercise (Fig. 5A). There was no difference in
RPE between trials at any time point (P 9 0.05). The median
RPE at end of the time trial was 19 (range = 3) arbitrary
units in both trials (P = 0.689). Thermal sensation gradually
increased throughout exercise (Fig. 5B) and was the same
in TYR and PLA throughout exercise (P 9 0.05). The median
ratings at end of the time trial were 7 (range = 5) arbitrary
units in TYR, representing a rating between ‘‘very hot, un-
comfortable’’ and ‘‘extremely hot, close to limit.’’ The median
thermal sensation at end of the time trial in PLA was similar
to TYR (P = 0.276) and was 8 (range, 6) arbitrary units
representing a rating of ‘‘extremely hot, close to limit.’’
Estimated substrate usage. Estimated fat (P = 0.253)
and carbohydrate (P = 0.290) oxidation rates and estimated
energy expenditure (P = 0.200) were unchanged from 30 to
50 min of constant-load submaximal-intensity exercise, and
were similar in both trials (P 9 0.05).
DISCUSSION
Previous studies have examined the effect of tyrosine ad-
ministration on exercise capacity in the heat in man (34,35),
but this is the first study to examine self-paced exercise per-
formance in the heat following acute oral tyrosine adminis-
tration. The present results demonstrate that, contrary to the
hypothesis, an acute administration of tyrosine did not im-
prove self-paced exercise performance in the heat compared
with a placebo containing an isocaloric quantity of hydro-
lyzed whey protein.
It was hypothesized that additional availability of tyro-
sine, a nutritional catecholamine precursor, would enhance
exercise tolerance in the heat, as reported in an earlier study
adopting a constant-load submaximal-intensity exercise pro-
tocol (34). In addition, it was expected that any performance
effect of tyrosine administration would be more pronounced
during a variable-intensity time trial, where subjects could
self-pace the exercise and thus the subjective effort, com-
pared with a constant-load trial. The similar power output
profiles in each time trial in the present study, and therefore
similar time to complete a set amount of work irrespective of
drink ingested, suggests that tyrosine has no performance
enhancing effect under the conditions of the present study.
This occurred despite a sound neurochemical basis for a
benefit of tyrosine administration before performance of a
time trial in the heat. The clear impairment in exercise per-
formance carried out in warm compared with cooler ambient
temperature (33) seems to be caused, in part, by alterations
in cerebral function, caused by high brain temperature,
resulting in reduced voluntary activation of muscle, increased
subjective effort, and reduced will or ‘‘drive’’ to exercise (21).
Changes in central catecholamine activity are implicated in
these processes because of their intrinsic connection with in-
creased arousal and motivation (4), thermoregulation (9,15),
and motor initiation and control (14). In addition, the phar-
macological augmentation of central catecholamine activity,
via acute bupropion administration, improves simulated time-
trial performance in the heat (30-C) but not in cooler condi-
tions (18-C) (36), highlighting the importance of cerebral
catecholamine activity in the ability to tolerate exercise with
heat stress. As tyrosine is a general catecholamine precur-
sor, the experimental drink may have augmented central
noradrenaline activity and this may offer partial explanation
for the present results. Recent work has reported an impairment
in time trial performance in the heat after an acute administra-
tion of a noradrenaline reuptake inhibitor, reboxetine, com-
pared with a lactose placebo (25). Enhanced noradrenaline
activity in the present study after tyrosine administration
may have constrained any performance effect during the
simulated time trial.
FIGURE 5—RPE (A) and thermal sensation ratings (B) during 60 min
of constant-load submaximal-intensity cycling and simulated cycling
time trial (TT), up to the last time point that all subjects were exercising
and value recorded at end of TT, in tyrosine (TYR) and placebo
(PLA) trials. *Significantly different versus 10 min rating in both
trials (P G 0.05). Data are expressed as mean T SD (n = 7).
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The current protocol was used on the basis that the com-
bination of exercise and heat stress would represent a suitably
demanding environment such that catecholamine neuronal
sensitivity would be up-regulated to precursor availability.
The absence of effect on exercise performance in the present
study occurred despite striking differences between the
plasma amino acid profiles between trials following drink
ingestion. The marked increase in the ratio of plasma tyrosine
plus phenylalanine to amino acids competing for brain up-
take after tyrosine administration was similar in magnitude
to one study in which exercise capacity in the heat was pro-
longed by 15%, 1 h after an administration of 150 mgIkgj1
tyrosine (34). This would favor the transport of tyrosine into
the brain at the expense of other neutral amino acids, which
compete for uptake at the blood–brain barrier (13). This
plasma ratio transiently declined after ingestion of the
placebo mixture in the present study which would reduce
brain entry of tyrosine (13).
At least one other study examining tyrosine administra-
tion before prolonged exercise in the heat provides support
for the idea that exercise tolerance in the heat is enhanced
after prior oral tyrosine administration (34). However, a sep-
arate study using a similar tyrosine dosage and exercise pro-
tocol reported no effect (35). It is not entirely clear why there
are discrepant findings between the present study and pre-
vious work reporting the benefit of tyrosine administration
before exercise in the heat (34). This could be related to the
degree of arousal and stress induced by the different pro-
tocols adopted, and therefore the degree of activation of the
central catecholaminergic system and the factors involved in
the regulation of tyrosine hydroxylase and catecholamine
synthesis described earlier. This may also explain why studies
examining acute tyrosine administration in man before ex-
ercise in temperate conditions have largely failed to report
beneficial effects on exercise capacity (30), simulated time-
trial performance (7), or muscle strength and anaerobic endur-
ance (31). Although it seems apparent that, in man, exercise
alone in the absence of heat stress is insufficiently demanding
to up-regulate catecholamine precursor demand (7,30), this
does not adequately explain the discrepant findings between
two studies adopting similar prolonged exercise protocols
in the heat and tyrosine dosage (34,35) and the underlying
reasons for this require further clarification. Perhaps the adop-
tion of a range of tyrosine doses in future work, particularly
higher doses than administered in the present study, may
identify whether there is an optimal dose which enhances
prolonged exercise in the heat.
As already mentioned, high brain catecholaminergic activ-
ity is associated with increased arousal and motivation (4);
therefore, an augmentation of central catecholamine after ty-
rosine administration might be expected to highlight differ-
ences in the power output profiles during the time trial or
the subjective response to exercise. By definition, a self-paced
time trial allows the power output throughout the time trial
and thus the relative metabolic demand to be controlled from
moment to moment. The time-trial power output data in the
present study suggest that subjects adopted an even-paced
strategy throughout the first 20 min of the time trial, repre-
senting the last common time point at which all subjects were
still exercising, and that plasma tyrosine availability did not
affect this pacing strategy. Some investigators suggest that
the adoption of a pacing strategy is necessary for the avoid-
ance of catastrophic failure of the organism (29). This is
hypothesized to involve feedback and feed-forward control
mechanisms in which the brain processes efferent neural com-
mands based on previous experience of similar situations to
elicit the most appropriate power output and metabolic rate
(29). The present power output data demonstrate that even
if a subconscious anticipation of the exercise power out-
put was adopted, tyrosine had no additional effect on this
compared with an isocaloric quantity of whey protein. Fur-
thermore, the present data suggest that the subjective inter-
pretation of the exercise cannot be manipulated by a plasma
amino acid profile, following the ingestion of the experi-
mental mixture, which would favor increased brain uptake
of a direct catecholamine precursor (13).
In summary, there was no effect of acute tyrosine adminis-
tration on simulated time-trial performance in the heat com-
pared with a placebo containing an isocaloric quantity of whey
protein. The lack of an association between increased tyrosine
availability and exercise performance suggests that, under
the conditions of the present study, acutely increasing plasma
tyrosine availability does not influence fatigue processes when
self-paced endurance exercise is performed with heat stress.
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